Stock analysis, AI verdict, fundamentals & technical signals
Rating: NEUTRAL
Price: $6.80 Analyst target: $7.00 Upside: 2.94%
Instil Bio, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer patients. The company is headquartered in Dallas, Texas.
See the full interactive analysis & chart →Informational only — not investment advice.